PATENT CLAIM ANALYSIS

Application Number: 15994786
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "007100"]

Abstract:
A method of bioassay for the quantification of peptide fragments elevated in lung diseases such as COPD, SCC, or IPF, comprising a neo-epitope formed at a cleavage site by cleavage in vivo of elastin by a proteinase by contacting a sample with an antibody having specific binding affinity for a the neo-epitope amino acid sequence and determining the level of binding, where the antibody binds one of the following terminal sequences: ...FGPGVV   ...VPGLGV   IKAPKL... and antibodies and immunoassay kits for use in such methods.

Claim (Index 3):
A cell line producing a monoclonal antibody as claimed in  claim 1 .

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.47619
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15111062', '12749652', '14116924', '14960713', '15446070']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6166439267661817
- 35 USC 102 Novelty (BERT): 0.6115363527629846
- Combined Prediction Score: 0.616133169365862
- Mean Citation Score: 374.239376
- Max Citation Score: 611.0979
- Similarity Product: 478.19435945443513

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test